Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is a malignant tumor in the respiratory system. The efficacy of current treatment modalities varies greatly, and individualization is evident. Therefore, finding biomarkers for predicting treatment prognosis and providing reference and guidance for formulating treatment op...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiang, Xu, Ran, Lu, Tong, Wang, Chenghao, Chang, Xiaoyan, Peng, Bo, Shen, Zhiping, Yao, Lingqi, Wang, Kaiyu, Xu, Chengyu, Shi, Jiaxin, Zhang, Ren, Zhao, Jiaying, Zhang, Linyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432465/
https://www.ncbi.nlm.nih.gov/pubmed/37587188
http://dx.doi.org/10.1038/s41598-023-40592-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432465/
https://www.ncbi.nlm.nih.gov/pubmed/37587188
http://dx.doi.org/10.1038/s41598-023-40592-w

Ejemplares similares